STOCK TITAN

Charles Schwab holds 3.64M shares of Accendra Health (ACH) — 4.75% stake

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Charles Schwab Investment Management Inc. filed Amendment No. 1 to a Schedule 13G/A reporting beneficial ownership of 3,635,526 shares of Accendra Health Inc. common stock (CUSIP 690732102), representing 4.75% of the class as of 03/31/2026. The filing shows sole voting and sole dispositive power over the same 3,635,526 shares. The amendment is signed by Omar Aguilar on 05/13/2026.

Positive

  • None.

Negative

  • None.

Insights

Large passive holding disclosed: 3,635,526 shares, 4.75% ownership.

The filing lists 3,635,526 shares and a 4.75% stake as of 03/31/2026. It is an amended Schedule 13G/A, which institutions commonly use to report passive or qualifying ownership.

Documented powers show sole voting and sole dispositive authority over 3,635,526 shares. Future disclosures may show changes if the holder crosses the 5% threshold or alters voting status.

Filing type Amendment No. 1 to Schedule 13G/A reporting beneficial ownership
Beneficial ownership 3,635,526 shares as of <date>03/31/2026</date>
Percent of class 4.75% reported in Item 4 of the amendment
Schedule 13G/A regulatory
"Amendment No. 1 to a Schedule 13G/A reporting beneficial ownership"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
Beneficially owned financial
"Amount beneficially owned: 3,635,526"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 3,635,526"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Charles Schwab hold in Accendra Health (ACH)?

Charles Schwab Investment Management Inc. reports beneficial ownership of 3,635,526 shares, equal to 4.75% of Accendra Health's common stock as of 03/31/2026. The filing lists sole voting and dispositive power over those shares.

Is this filing an initial report or an amendment for ACH?

This submission is labeled Amendment No. 1 to a Schedule 13G/A. It updates prior reporting and is signed on 05/13/2026, reflecting the holder's reported position as of 03/31/2026.

Does Charles Schwab have voting control over the shares of ACH?

Yes. The filing states Charles Schwab has sole power to vote and sole power to dispose of 3,635,526 shares of Accendra Health common stock, per the ownership table in the amendment.

Does this Schedule 13G/A indicate Charles Schwab is a 5% owner of ACH?

No. The amendment explicitly categorizes the position as "Ownership of 5 Percent or Less of a Class" and reports a 4.75% stake, which is below the 5% reporting threshold stated in the filing.





690732102

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Signature:/s/ Omar Aguilar
Name/Title:Omar Aguilar/Chief Executive Officer
Date:05/13/2026